DiVincenzo Jonathan P.
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1453524. Latest Form 4 filed Oct 27, 2026.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Bio-Rad Laboratories, Inc.BIO | President & COO, Officer | 3 | 2026-10-24 | 2026-10-24 |
Transactions: 3
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-24 | Bio-Rad Laboratories, Inc.President & COO, Officer | Option exerciseRestricted Stock Units | 1,869 | $0.00 | $0 | Form 4 |
| 2026-10-24 | Bio-Rad Laboratories, Inc.President & COO, Officer | Tax withholding | 951 | $369.95 | $351.8k | Form 4 |
| 2026-10-24 | Bio-Rad Laboratories, Inc.President & COO, Officer | Option exercise | 1,869 | $0.00 | $0 | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 03:21 ET. Listed shows no prices and gives no investment advice.